enfortumab vedotin as treatment for urothelial carcinomas
Published 5 years ago • 576 plays • Length 3:24Download video MP4
Download video MP3
Similar videos
-
0:30
enfortumab vedotin plus pembrolizumab for advanced urothelial carcinoma
-
1:58
enfortumab vedotin for the treatment of advanced urothelial cancer
-
2:10
initial ev-103 results: enfortumab vedotin plus pembrolizumab for urothelial carcinoma
-
6:09
enfortumab vedotin for previously-treated advanced urothelial carcinoma
-
2:39
enfortumab vedotin approved by fda for patients with refractory urothelial carcinoma
-
4:21
sacituzumab govitecan plus enfortumab vedotin for treatment of advanced urothelial cancer
-
0:49
evolving landscape of urothelial cancer treatment: erdafitinib or enfortumab vedotin?
-
0:34
enfortumab vedotin for urothelial cancer in the real-world setting
-
2:09
enfortumab vedotin for bladder cancer
-
3:07
enfortumab vedotin in urothelial cancer
-
3:25
enfortumab vedotin with pembrolizumab for bladder cancer
-
2:20
ev-201: enfortumab vedotin for bladder cancer
-
2:52
enfortumab vedotin in urothelial cancer
-
0:34
pembrolizumab plus enfortumab vedotin for bladder cancer
-
2:23
enfortumab vedotin–pembrolizumab in advanced urothelial cancer | nejm
-
13:47
ev-103: enfortumab vedotin and pembrolizumab in urothelial carcinoma
-
2:58
ev-201: enfortumab vedotin for cisplatin-ineligible bladder cancer
-
4:34
optimising treatment for advanced urothelial cancer: combination, maintenance or sequencing?
-
1:21
enfortumab vedotin and pembrolizumab vs platinum-based combination therapies for patients with muc